亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Aspirin in hepatocellular carcinoma: is it an out-of-date or promising treatment?

阿司匹林 医学 肝细胞癌 背景(考古学) 癌症 内科学 肝硬化 乙型肝炎 胃肠病学 肿瘤科
作者
Xun Qiu,Fengqiang Gao,Kai Wang,Zhensheng Zhang,Chuxiao Shao,Xiao Xu
出处
期刊:iLIVER
标识
DOI:10.1016/j.iliver.2022.03.003
摘要

Hepatocellular carcinoma (HCC) is one of the most aggressive human malignancies with a dismal survival rate. Few strategies can effectively prevent the occurrence of HCC. Although immunotherapy has significantly improved HCC-related survival in recent years, this systemic therapy is very expensive and lays a heavy burden on most HCC patients. Aspirin, which is currently one of the most widely used medications in analgesic and cardiovascular diseases, is reported to have anti-tumor effects on HCC. Most importantly, long-term administration of low-dose aspirin does not significantly increase the risk of gastrointestinal bleeding. Owing to its cost-effectiveness and wide use, aspirin can be easily applied as an HCC treatment and is affordable for a wide range of patients. Therefore, deeper understanding and more attention are needed to extend the frontline of aspirin's preventive and therapeutic potential into cancer research and management. In this review, we discuss the preventive effect of aspirin on HCC in the context of different etiological factors, including hepatitis B or hepatitis C virus infection, non-alcoholic fatty liver disease, and alcohol-associated liver disease. The therapeutic role of aspirin in resectable or unresectable HCC management is also discussed. Furthermore, the mechanisms underlying the anti-cancer effects of aspirin on HCC are fully reviewed and discussed in the following two aspects: the effect of aspirin on multi-oncogenic signaling pathways in HCC (e.g., AMPK, Wnt/β-catenin, NF-κB) and aspirin-mediated immunometabolic responses in liver diseases. These findings indicate aspirin is a promising agent for populations at risk and HCC patients to prevent or treat HCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
16秒前
21秒前
SemiConduAG完成签到,获得积分10
23秒前
蓝色逍遥鱼完成签到,获得积分10
26秒前
英俊的铭应助科研通管家采纳,获得10
28秒前
SciGPT应助科研通管家采纳,获得10
28秒前
31秒前
ste56发布了新的文献求助10
36秒前
xz完成签到 ,获得积分10
36秒前
36秒前
Llawite发布了新的文献求助10
42秒前
Llawite完成签到,获得积分20
54秒前
54秒前
锋芒不毕露完成签到,获得积分10
55秒前
1分钟前
1分钟前
材料摆渡人完成签到,获得积分10
1分钟前
1分钟前
章鱼小丸子完成签到,获得积分10
1分钟前
1分钟前
1分钟前
欢喜怀绿发布了新的文献求助10
1分钟前
1分钟前
2分钟前
今后应助陈昇采纳,获得10
2分钟前
今后应助科研通管家采纳,获得30
2分钟前
慕青应助科研通管家采纳,获得10
2分钟前
2分钟前
陈昇发布了新的文献求助10
2分钟前
田恬完成签到,获得积分10
2分钟前
英俊的铭应助超帅的萤采纳,获得10
3分钟前
徐浩彬完成签到 ,获得积分10
3分钟前
3分钟前
Lih完成签到 ,获得积分10
3分钟前
超帅的萤发布了新的文献求助10
3分钟前
立邦芝士完成签到,获得积分10
3分钟前
超帅的萤完成签到,获得积分10
3分钟前
3分钟前
3分钟前
pjh发布了新的文献求助10
3分钟前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Semiconductor Process Reliability in Practice 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 600
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3234546
求助须知:如何正确求助?哪些是违规求助? 2880894
关于积分的说明 8217276
捐赠科研通 2548495
什么是DOI,文献DOI怎么找? 1377786
科研通“疑难数据库(出版商)”最低求助积分说明 647999
邀请新用户注册赠送积分活动 623327